JP2002255771A - Liquid composition for oral cavity not mixed with alcohol - Google Patents

Liquid composition for oral cavity not mixed with alcohol

Info

Publication number
JP2002255771A
JP2002255771A JP2001050116A JP2001050116A JP2002255771A JP 2002255771 A JP2002255771 A JP 2002255771A JP 2001050116 A JP2001050116 A JP 2001050116A JP 2001050116 A JP2001050116 A JP 2001050116A JP 2002255771 A JP2002255771 A JP 2002255771A
Authority
JP
Japan
Prior art keywords
alcohol
polyethylene glycol
weight
cationic
oral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001050116A
Other languages
Japanese (ja)
Other versions
JP4674980B2 (en
Inventor
Toru Saito
徹 齋藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP2001050116A priority Critical patent/JP4674980B2/en
Publication of JP2002255771A publication Critical patent/JP2002255771A/en
Application granted granted Critical
Publication of JP4674980B2 publication Critical patent/JP4674980B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a liquid composition for the oral cavity not mixed with alcohol, controlling coloration of teeth with a cationic germicide. SOLUTION: This liquid composition for the oral cavity not mixed with alcohol controls the coloration of teeth with the cationic germicide by formulating (a) a cationic germicide with (b) a polyoxyethylene hardened castor oil and (c) a polyethylene glycol having 200-800 average molecular weight.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、カチオン系殺菌剤
による歯牙の着色を抑制したアルコール無配合液体口腔
用組成物に関する。
[0001] The present invention relates to a liquid oral composition containing no alcohol, which suppresses the coloring of teeth by a cationic fungicide.

【0002】[0002]

【従来の技術】虫歯や歯周炎の原因である歯垢(プラー
ク)の除去や付着予防(プラークコントロール)は、口
腔衛生において重要である。従来、プラーク細菌を殺菌
する目的でカチオン系抗菌剤を配合した口腔用組成物が
提案されている。しかし、カチオン系殺菌剤を長期間使
用すると、歯牙が着色するという問題がある。
2. Description of the Related Art Removal of plaque (plaque) which causes caries and periodontitis and prevention of adhesion (plaque control) are important in oral hygiene. BACKGROUND ART Conventionally, oral compositions containing a cationic antibacterial agent for the purpose of sterilizing plaque bacteria have been proposed. However, when a cationic fungicide is used for a long time, there is a problem that teeth are colored.

【0003】カチオン系殺菌剤の使用による歯牙着色の
問題を解決するため、例えば、WO-9316681に
は、カチオン性殺菌剤とポリビニルピロリドンとを併用
してなる口腔用組成物によって、カチオン系殺菌剤によ
る歯牙の着色を抑制するとこが記載されている。しか
し、ポリビニルピロリドンは製剤系での安定性が悪く、
長期保存により製剤の変色が起こるという問題がある。
また、特開昭57-188510号公報には、第4級アン
モニウム化合物とテトラアルカリ金属のピロリン酸塩を
特定のpHに調整することにより、第4級アンモニウム
化合物由来の歯牙着色を減少させることが記載されてい
る。しかし、テトラアルカリ金属のピロリン酸塩は味が
悪いという問題がある。すなわち上記のいずれの場合で
も、その効果は十分であるとはいえない。
[0003] In order to solve the problem of tooth coloring caused by the use of a cationic fungicide, for example, WO-9316681 discloses a cationic fungicide by using an oral composition comprising a combination of a cationic fungicide and polyvinylpyrrolidone. It is described that the coloring of the teeth due to is suppressed. However, polyvinylpyrrolidone has poor stability in pharmaceutical systems,
There is a problem that discoloration of the preparation occurs due to long-term storage.
JP-A-57-188510 discloses that by adjusting the pH of a quaternary ammonium compound and a tetraalkali metal pyrophosphate to a specific pH, tooth coloring derived from a quaternary ammonium compound can be reduced. Has been described. However, tetraalkali metal pyrophosphate has a problem that taste is bad. That is, in any of the above cases, the effect cannot be said to be sufficient.

【0004】ポリエチレングリコールは、主に分散剤や
湿潤剤として製剤の安定化を目的として配合されてい
る。例えば、特開昭56−77221号公報にはアニオ
ン性活性剤を含有する透明の歯磨組成物中に、特定のポ
リエチレングリコ−ルを配合することで、低温下におけ
るアニオン性活性剤の析出を防止できることが記載され
ている。また、特開平03−109315号公報には、
ポリオキシエチレン・ポリオキシプロピレンブロツクコ
ポリマ−系界面活性剤で構成される水性ゲルに、塩化セ
チルピリジニウムおよび特定量のポリエチレングリコ−
ルで配合することにより塩化セチルピリジニウムを安定
に配合し、良好な性状を有する歯磨組成物について記載
されている。さらに、特表平09−510192号公報
には、キサンタンガム等の沈澱防止剤により安定に懸濁
された、粒状シリカ研磨剤と、ソルビト−ル及び特定分
子量のポリエチレングリコ−ルを含む湿潤剤系とからな
る液体歯磨剤は、歯の浄化性に優れていることが記載さ
れている。これらはいずれもカチオン系殺菌剤による歯
牙着色の抑制については言及されていない。
[0004] Polyethylene glycol is mainly blended as a dispersant or wetting agent for the purpose of stabilizing the preparation. For example, JP-A-56-77221 discloses that a specific polyethylene glycol is blended in a transparent dentifrice composition containing an anionic activator to prevent precipitation of the anionic activator at a low temperature. It states that it can. Also, JP-A-03-109315 discloses that
An aqueous gel composed of a polyoxyethylene / polyoxypropylene block copolymer-based surfactant is mixed with cetylpyridinium chloride and a specific amount of polyethylene glycol.
A dentifrice composition which stably blends cetylpyridinium chloride by blending with benzene and has good properties is described. Further, Japanese Patent Application Laid-Open No. 09-510192 discloses a particulate silica abrasive stably suspended with a precipitation inhibitor such as xanthan gum, a wetting agent system containing sorbitol and polyethylene glycol of a specific molecular weight. It is described that a liquid dentifrice comprising is excellent in tooth cleaning properties. None of them mentions the suppression of tooth coloring by a cationic fungicide.

【0005】[0005]

【発明が解決しようとする課題】すなわち、本発明はカ
チオン系殺菌剤による歯牙着色を抑制した1価アルコー
ル無配合液体口腔用組成物を提供するものである。
That is, an object of the present invention is to provide a liquid oral composition containing no monohydric alcohol, which suppresses tooth coloring by a cationic fungicide.

【0006】[0006]

【問題点を解決するための手段】本発明者らはかかる事
情に鑑み鋭意検討をかさねた結果、カチオン系殺菌剤に
ポリオキシエチレン硬化ヒマシ油およびポリエチレング
リコールを配合したアルコール無配合の液体口腔用組成
物は、カチオン系殺菌剤による歯牙の着色を抑制するこ
とを見出し、本発明を完成するに至った。
Means for Solving the Problems The inventors of the present invention have made intensive studies in view of such circumstances, and as a result, have found that a liquid oral cavity containing no alcohol containing a polyoxyethylene hydrogenated castor oil and polyethylene glycol mixed with a cationic fungicide. The composition has been found to inhibit the coloring of teeth by a cationic fungicide, and has completed the present invention.

【0007】[0007]

【発明の実施の形態】本発明のアルコール無配合液体口
腔用組成物で用いるカチオン系殺菌剤は、特に限定され
るものではないが、塩化セチルピリジニウムまたはクロ
ルヘキシジン塩類が好ましい。その配合量は、組成物全
量に対して0.01〜0.1重量%であり、0.01重
量%より少ないと、充分な殺菌効果が発揮されず、0.
1重量%より多いと、苦味の問題が起こることがある。
BEST MODE FOR CARRYING OUT THE INVENTION The cationic fungicide used in the alcohol-free liquid oral composition of the present invention is not particularly limited, but cetylpyridinium chloride or chlorhexidine salts are preferred. The compounding amount is from 0.01 to 0.1% by weight based on the total amount of the composition.
If it is more than 1% by weight, bitterness may occur.

【0008】本発明の1価アルコール無配合液体口腔用
組成物で用いるポリオキシエチレン硬化ヒマシ油は、特
に限定されるものではないが、そのエチレンオキサイド
の付加モル数が10〜100モルが好ましく、特に40
〜60モルが好ましい。またその配合量は、組成物全量
に対して0.01〜5重量%が好ましく、0.1〜1重
量%が特に好ましい。0.01重量%より少ないと、充
分な可溶化力が得られない場合があり、5重量%より多
いと、ミセル中へのカチオン系殺菌剤の取り込みによる
殺菌活性の低下が生じる恐れがある。
[0008] The polyoxyethylene hydrogenated castor oil used in the liquid oral composition containing no monohydric alcohol of the present invention is not particularly limited, but the number of moles of ethylene oxide added is preferably 10 to 100 moles. Especially 40
~ 60 mol is preferred. The compounding amount is preferably from 0.01 to 5% by weight, particularly preferably from 0.1 to 1% by weight, based on the total amount of the composition. If the amount is less than 0.01% by weight, sufficient solubilizing power may not be obtained, and if the amount is more than 5% by weight, the bactericidal activity may decrease due to incorporation of the cationic bactericide into micelles.

【0009】本発明のポリエチレングリコールは、その
平均分子量が200〜800が好ましく、その配合量
は、カチオン性殺菌剤の配合量に対しての配合量比が、
1:30〜1:100が好ましく、且つ、組成物全量に
対し1〜5重量%が好ましい。1重量%より少ないと歯
牙着色の抑制が不十分で、5重量%より多いと苦味の問
題が生じる。
[0009] The polyethylene glycol of the present invention preferably has an average molecular weight of 200 to 800.
It is preferably from 1:30 to 1: 100, and more preferably from 1 to 5% by weight based on the total amount of the composition. If it is less than 1% by weight, suppression of tooth coloring is insufficient, and if it is more than 5% by weight, a problem of bitterness occurs.

【0010】本発明のアルコール無配合液体口腔用組成
物は、液体歯磨、マウスウォシュ、リンス、低粘度ジェ
ルなどの形態で提供できる。ここでいうアルコール無配
合液体口腔用組成物とは1価アルコール無配合液体口腔
用組成物、特にエタノール無配合無配合液体口腔用組成
物であることを示す。
[0010] The alcohol-free liquid oral composition of the present invention can be provided in the form of liquid dentifrice, mouthwash, rinse, low-viscosity gel and the like. The term “alcohol-free liquid oral composition” as used herein means a monohydric alcohol-free liquid oral composition, particularly an ethanol-free liquid-free oral composition.

【0011】本発明のアルコール無配合液体口腔用組成
物は前記の成分に加えて、さらに組成物の形態に応じた
以下のような適当な成分を本発明の効果を損なわない範
囲で配合することができる。
[0011] In addition to the above components, the alcohol-free liquid oral composition of the present invention may further contain the following appropriate components according to the form of the composition as long as the effects of the present invention are not impaired. Can be.

【0012】例えば、界面活性剤として、ノニオン界面
活性剤または両性界面活性剤から選べられる。例えば、
ノニオン界面活性剤としてはショ糖脂肪酸エステル、マ
ルトース脂肪酸エステル、ラクトース脂肪酸エステルな
どの糖脂肪酸エステル、脂肪酸アルカノールアミド類、
ソルビタン脂肪酸エステル、脂肪酸モノグリセライド、
ポリオキシエチレン付加係数が8〜10、アルキル基の
炭素数が13〜15であるポリオキシエチレンアルキル
エーテル系またはポリオキシエチレン付加係数が10〜
18、アルキル基の炭素数が9であるポリオキシエチレ
ンアルキルフェニルエーテル系ノニオン界面活性剤など
が挙げられる。両性イオン界面活性剤としては、Nーラ
ウリルジアミノエチルグリシン、Nーミリスチルジエチ
ルグリシンなどのNーアルキルジアミノエチルグリシ
ン、NーアルキルーNーカルボキシメチルアンモニウム
ベタイン、2−アルキル−1ヒドロキシエチルイミダゾ
リンベタインナトリウムがあげられる。これらの界面活
性剤は、単独または2種以上を組み合わせて配合するこ
とができる。その配合量は、通常、組成物全量に対して
0.01〜30重量%、好ましくは0.1〜5重量%で
ある。
For example, the surfactant can be selected from nonionic surfactants and amphoteric surfactants. For example,
Nonionic surfactants include sucrose fatty acid esters, maltose fatty acid esters, sugar fatty acid esters such as lactose fatty acid esters, fatty acid alkanolamides,
Sorbitan fatty acid esters, fatty acid monoglycerides,
Polyoxyethylene addition coefficient is 8 to 10, polyoxyethylene alkyl ether type having 13 to 15 carbon atoms in the alkyl group or polyoxyethylene addition coefficient is 10 to 10.
18, a polyoxyethylene alkylphenyl ether nonionic surfactant having an alkyl group having 9 carbon atoms, and the like. Examples of the amphoteric surfactant include N-alkyldiaminoethylglycine such as N-lauryldiaminoethylglycine and N-myristyldiethylglycine, N-alkyl-N-carboxymethylammonium betaine, and sodium 2-alkyl-1-hydroxyethylimidazoline betaine. Can be These surfactants may be used alone or in combination of two or more. The compounding amount is usually 0.01 to 30% by weight, preferably 0.1 to 5% by weight based on the total amount of the composition.

【0013】香味剤として、メントール、カルボン酸、
アネトール、オイゲノール、サリチル酸メチル、リモネ
ン、オシメン、n−デシルアルコール、シトロネール、
α−テルピネオール、メチルアセタート、シトロネニル
アセタート、メチルオイゲノール、シネオール、リナロ
ール、エチルリナロール、チモール、スペアミント油、
ペパーミント油、レモン油、オレンジ油、セージ油、ロ
ーズマリー油、珪皮油、シソ油、冬緑油、丁子油、ユー
カリ油、ピメント油などの香料を、単独または2種以上
を組み合わせて組成物全量に対して0.1〜重量%、好
ましくは0.5〜5重量%程度の割合で配合することが
できる。
As a flavoring agent, menthol, carboxylic acid,
Anethole, eugenol, methyl salicylate, limonene, ocimene, n-decyl alcohol, citronell,
α-terpineol, methyl acetate, citronenyl acetate, methyl eugenol, cineol, linalool, ethyl linalool, thymol, spearmint oil,
A composition comprising a fragrance such as peppermint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, perilla oil, winter green oil, clove oil, eucalyptus oil, and pigment oil, alone or in combination of two or more. It can be blended at a ratio of about 0.1 to about 5% by weight, preferably about 0.5 to 5% by weight based on the total amount.

【0014】また、サッカリンナトリウム、アセスルフ
ァームカリウム、ステビオサイド、ネオヘスペリジルジ
ヒドロカルコン、グリチルリチン、ペリラルチン、タウ
マチン、アスパラチルフェニルアラニルメチルエステ
ル、ρ−メトキシシンナミックアルデヒドなどの甘味剤
を、組成物全量に対して0.01〜1重量%、好ましく
は0.05〜0.5重量%の割合で配合することができ
る。
Further, a sweetener such as saccharin sodium, acesulfame potassium, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, perillartin, thaumatin, asparatyl phenylalanyl methyl ester, and ρ-methoxycinnamic aldehyde is added to the total amount of the composition. It can be added at a ratio of 0.01 to 1% by weight, preferably 0.05 to 0.5% by weight.

【0015】本発明の口腔用組成物においては、使用感
を損なわない程度の粘性を持たせるために、カチオン化
ヒドロキシエチルセルロース、アルギン酸ナトリウムな
どのアルカリ金属アルギネート、アルギン酸プロピレン
グリコールエステル、キサンタンガム、トラガントガ
ム、カラヤガム、アラビヤガム、カラギーナンなどのガ
ム類、ポリビニルアルコール、ポリアクリル酸ナトリウ
ム、カルボキシビニルポリマー、ポリビニルピロリドン
などの合成粘結剤、シリカゲル、アルミニウムシリカゲ
ル、ビーガム、ラポナイトなどの無機粘結剤なとの1種
又は2種以上が配合され得る。これらの配合量は通常
0.1重量%以下である。
In the oral composition of the present invention, alkali metal alginate such as cationized hydroxyethylcellulose and sodium alginate, propylene glycol alginate, xanthan gum, tragacanth gum and karaya gum are used in order to impart a viscosity that does not impair the feeling of use. Gums such as gum arabic, carrageenan, polyvinyl alcohol, sodium polyacrylate, carboxyvinyl polymer, synthetic binders such as polyvinylpyrrolidone, silica gel, aluminum silica gel, veegum, one of inorganic binders such as laponite or Two or more can be blended. The amount of these compounds is usually 0.1% by weight or less.

【0016】さらに、湿潤剤として、ソルビット、グリ
セリン、エチレングリコール、プロピレングリコール、
1,3―ブチレングリコール、ポリプロピレングリコー
ル、キシリット、マルチット、ラクチットなどを単独ま
たは2種以上を組み合わせて配合することができる。配
合量は、通常、組成物全量に対して3〜70重量%であ
Further, as humectants, sorbitol, glycerin, ethylene glycol, propylene glycol,
1,3-butylene glycol, polypropylene glycol, xylit, maltit, lactit and the like can be used alone or in combination of two or more. The compounding amount is usually 3 to 70% by weight based on the total amount of the composition.

【0017】なお、本発明の口腔用組成物には、カチオ
ン性殺菌剤以外の薬効成分として、酢酸dl−α−トコ
フェロール、コハク酸トコフェロール、またはニコチン
酸トコフェロールなどのビタミンE類、ドデシルジアミ
ノエチルグリシンなどの両性殺菌剤、トリクロサン、イ
ソプロピルメチルフェノールなどの非イオン性殺菌剤、
デキストラナーゼ、アミラーゼ、プロテアーゼ、ムタナ
ーゼ、リゾチーム、溶菌酵素(リテックエンザイム)な
どの酵素、モノフルオロリン酸ナトリウム、モノフルオ
ロリン酸カリウムなどのアルカリ金属モノフルオロフォ
スフェート、フッ化ナトリウム、フッ化第一錫などのフ
ッ化物、トラネキサム酸やイプシロンアミノカプロン
酸、アルミニウムクロルヒドロキシルアラントイン、ジ
ヒドロコレステロール、グリチルリチン塩類、グリチル
レチン酸、グリセロフォスフェート、クロロフィル、塩
化ナトリウム、カロペプタイド、水溶性無機リン酸化合
物などを、単独または2種以上を組み合わせて配合する
ことができる。
In the oral composition of the present invention, vitamin E such as dl-α-tocopherol acetate, tocopherol succinate or tocopherol nicotinate, and dodecyl diaminoethyl glycine as active ingredients other than the cationic bactericide. Non-ionic fungicides such as amphoteric fungicides, triclosan, isopropylmethylphenol, etc.
Enzymes such as dextranase, amylase, protease, mutanase, lysozyme, and lytic enzyme (Litek enzyme), alkali metal monofluorophosphates such as sodium monofluorophosphate and potassium monofluorophosphate, sodium fluoride, and first fluoride Fluoride such as tin, tranexamic acid or epsilon aminocaproic acid, aluminum chlorohydroxyl allantoin, dihydrocholesterol, glycyrrhizin salts, glycyrrhetinic acid, glycerophosphate, chlorophyll, sodium chloride, caropeptide, water-soluble inorganic phosphate compound, etc. More than one species can be combined and blended.

【0018】[0018]

【実施例】以下の実施例により本発明をさらに詳細する
が、本発明はこれらの実施例に限定されるものではな
い。実施例中、[%]は特に断らない限り[重量%]で
ある。以下に評価方法を示す。 1.歯牙着色評価試験 アクリル板(10mm×30mm×5mm)を0.3%
牛血清アルブミンに2分間漬す。そのアクリル板を蒸留
水に30秒間浸漬して洗浄後、試験サンプルに2分間漬
す。蒸留水に30秒間浸漬して洗浄後、紅茶(10g/
1000ml沸騰水で抽出し、2分後にガーゼに通して
葉を取り除いたもの)に60分間漬す。蒸留水に30秒
間浸漬して洗浄後、自然乾燥する。上記の操作を10回
繰り返し、アクリル板表面の着色を、測定波長395n
mで吸光度を測定する。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples. In Examples, [%] is [% by weight] unless otherwise specified. The evaluation method is described below. 1. Tooth coloring evaluation test Acrylic plate (10 mm x 30 mm x 5 mm) 0.3%
Soak in bovine serum albumin for 2 minutes. The acrylic plate is immersed in distilled water for 30 seconds, washed, and then immersed in a test sample for 2 minutes. After washing by immersion in distilled water for 30 seconds, black tea (10 g /
Extracted with 1000 ml of boiling water and passed through gauze after 2 minutes to remove the leaves) and soaked for 60 minutes. After washing by immersion in distilled water for 30 seconds, air drying is performed. The above operation was repeated 10 times, and the coloring of the acrylic plate surface was measured at a measurement wavelength of 395 n.
Measure absorbance in m.

【0019】2.評価基準:吸光度に応じて下記の通り
に評した。 評価基準の数値が大きいほど歯牙着色抑制効果が高いこ
とを示す。結果を表1に示す。
2. Evaluation criteria: Evaluation was made as follows according to the absorbance. The larger the value of the evaluation criterion, the higher the effect of suppressing tooth coloring. Table 1 shows the results.

【0020】[0020]

【表1】 [Table 1]

【0021】表1の結果により、平均分子量200〜8
00のポリエチレングリコールを1.0%〜5.0%配
合した実施例1〜3の試験サンプルは、ポリエチレング
リコールを無配合の比較例1、または平均分子量100
0のポリエチレングリコールを配合した比較例2及び3
の試験サンプルに比べて、歯牙着色抑制効果が極めて優
れていることが明らかである。さらに比較例4の試験サ
ンプルのようにポリオキシエチレン硬化ヒマシ油を無配
合の場合、実施例1、4の試験サンプルのような効果が
見られないことが分かった。
According to the results shown in Table 1, the average molecular weight is 200 to 8
The test samples of Examples 1 to 3 containing 1.0% to 5.0% of polyethylene glycol of Comparative Example 1 were Comparative Example 1 containing no polyethylene glycol or having an average molecular weight of 100.
Comparative Examples 2 and 3 containing 0 polyethylene glycol
It is clear that the tooth coloring inhibition effect is extremely excellent as compared with the test sample of Example 1. Furthermore, when the polyoxyethylene hydrogenated castor oil was not blended as in the test sample of Comparative Example 4, it was found that the effects as in the test samples of Examples 1 and 4 were not obtained.

【0022】実施例5 以下の処方により、常法に従い、マウスウォッシュを製
造した。 成分名 配合量(%) グリセリン 15.0 ポリオキシエチレン硬化ヒマシ油( EO) 4.0 ポリエチレングリコール400 3.0 香料 0.1 サッカリンナトリウム 0.01 塩化セチルピリジニウム 0.05 クエン酸ナトリウム 0.05 酢酸トコフェロール 0.02 フッ化ナトリウム 0.05 精製水 残部 合計 100.0 得られたマウスウォッシュについては、上記の歯牙着色
評価試験法で評価したところ、優れた抑制効果を示し
た。
Example 5 A mouthwash was produced according to the following formulation according to a conventional method. Component name Content (%) Glycerin 15.0 Polyoxyethylene hydrogenated castor oil (EO) 4.0 Polyethylene glycol 400 3.0 Fragrance 0.1 Sodium saccharin 0.01 Cetylpyridinium chloride 0.05 Sodium citrate 0.05 Acetic acid Tocopherol 0.02 Sodium fluoride 0.05 Purified water Remainder Total 100.0 The obtained mouthwash was evaluated by the above-described tooth coloring evaluation test method and showed an excellent inhibitory effect.

【0023】実施例6 以下の処方により、常法に従い、液体歯磨剤を製造し
た。 成分名 配合量(%) ソルビット 10.0 ポリオキシエチレン硬化ヒマシ油( EO) 5.0 香料 0.05 ポリエチレングリコール400 5.0 サッカリンナトリウム 0.01 グルコン酸クロルヘキシジン 0.05 クエン酸ナトリウム 0.05 酢酸トコフェロール 0.02 フッ化ナトリウム 0.05 精製水 残部 合計 100.0 得られた液体歯磨剤については、上記の歯牙着色評価試
験法で評価したところ、優れた抑制効果を示した。
Example 6 A liquid dentifrice was produced according to the following formulation according to a conventional method. Component name Content (%) Sorvit 10.0 Polyoxyethylene hydrogenated castor oil (EO) 5.0 Fragrance 0.05 Polyethylene glycol 400 5.0 Saccharin sodium 0.01 Chlorhexidine gluconate 0.05 Sodium citrate 0.05 Acetic acid Tocopherol 0.02 Sodium fluoride 0.05 Purified water Remainder Total 100.0 The obtained liquid dentifrice was evaluated by the above-described tooth coloring evaluation test method and showed an excellent inhibitory effect.

【0024】実施例7 以下の処方により、常法に従い、低粘度ジェルを製造し
た。 成分名 配合量(%) ソルビット 10.0 ポリオキシエチレン硬化ヒマシ油( EO) 3.0 香料 0.2 ポリエチレングリコール400 1.0 サッカリンナトリウム 0.01 グルコン酸クロルヘキシジン 0.05 ヒドロキシエチルセルロース 0.01 酢酸トコフェロール 0.05 フッ化ナトリウム 0.05 精製水 残部 合計 100.0 得られた低粘度ジェルについては、上記の歯牙着色評価
試験法で評価したところ、優れた抑制効果を示した。
Example 7 A low-viscosity gel was produced according to the following formulation according to a conventional method. Component name Content (%) Sorbit 10.0 Polyoxyethylene hydrogenated castor oil (EO) 3.0 Fragrance 0.2 Polyethylene glycol 400 1.0 Saccharin sodium 0.01 Chlorhexidine gluconate 0.05 Hydroxyethyl cellulose 0.01 Tocopherol acetate 0.05 Sodium fluoride 0.05 Purified water Remainder Total 100.0 The obtained low-viscosity gel was evaluated by the above-mentioned tooth coloring evaluation test method, and showed an excellent inhibitory effect.

【0025】[0025]

【発明の効果】 カチオン系殺菌剤にポリオキシエチレ
ン硬化ヒマシ油およびポリエチレングリコールを配合す
る本発明によれば、カチオン系殺菌剤による歯牙の着色
を抑制するアルコール無配合の液体口腔用組成物が提供
できる。
Effect of the Invention According to the present invention in which polyoxyethylene hydrogenated castor oil and polyethylene glycol are blended with a cationic fungicide, an alcohol-free liquid oral composition that suppresses tooth coloring by the cationic fungicide is provided. it can.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 (a)カチオン系殺菌剤、(b)ポリオキシエ
チレン硬化ヒマシ油、(c)平均分子量が200から80
0のポリエチレングリコールを含有することを特徴とす
るアルコール無配合液体口腔用組成物。
1. A cationic fungicide, (b) polyoxyethylene hydrogenated castor oil, and (c) an average molecular weight of 200 to 80.
An alcohol-free liquid oral composition comprising 0 polyethylene glycol.
【請求項2】 カチオン系殺菌剤が塩化セチルピリジニ
ウムまたはクロルヘキシジン塩類である請求項1記載の
アルコール無配合液体口腔用組成物。
2. The liquid oral composition according to claim 1, wherein the cationic fungicide is cetylpyridinium chloride or chlorhexidine salt.
【請求項3】 カチオン系殺菌剤の配合量が0.01〜
0.1重量%ある請求項1、2の何れか1項に記載のア
ルコール無配合液体口腔用組成物。
3. The compounding amount of the cationic bactericide is 0.01 to 3.0.
The alcohol-free liquid oral composition according to any one of claims 1 and 2, which is 0.1% by weight.
【請求項4】 カチオン性殺菌剤に対するポリエチレン
グリコールの配合量比が、1:30〜1:100、且つ
ポリエチレングリコールの配合量が成物全量に対し1〜
5重量%である請求項1〜4の何れか1項に記載のアル
コール無配合液体口腔用組成物。
4. The compounding ratio of polyethylene glycol to the cationic germicide is 1:30 to 1: 100, and the compounding amount of polyethylene glycol is 1 to 1 to the total amount of the composition.
The alcohol-free liquid oral composition according to any one of claims 1 to 4, which is 5% by weight.
JP2001050116A 2001-02-26 2001-02-26 Alcohol-free liquid oral composition Expired - Lifetime JP4674980B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001050116A JP4674980B2 (en) 2001-02-26 2001-02-26 Alcohol-free liquid oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001050116A JP4674980B2 (en) 2001-02-26 2001-02-26 Alcohol-free liquid oral composition

Publications (2)

Publication Number Publication Date
JP2002255771A true JP2002255771A (en) 2002-09-11
JP4674980B2 JP4674980B2 (en) 2011-04-20

Family

ID=18911129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001050116A Expired - Lifetime JP4674980B2 (en) 2001-02-26 2001-02-26 Alcohol-free liquid oral composition

Country Status (1)

Country Link
JP (1) JP4674980B2 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015502978A (en) * 2011-12-21 2015-01-29 ブリガム ヤング ユニバーシティ Oral care composition
US9314472B2 (en) 2012-10-17 2016-04-19 Brigham Young University Treatment and prevention of mastitis
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
US9546195B2 (en) 2011-07-20 2017-01-17 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
JP2017031201A (en) * 2016-09-30 2017-02-09 ブリガム ヤング ユニバーシティ Oral care composition
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10626139B2 (en) 2014-02-27 2020-04-21 Brigham Young University Cationic steroidal antimicrobial compounds
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11286276B2 (en) 2014-01-23 2022-03-29 Brigham Young University Cationic steroidal antimicrobials
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US11739116B2 (en) 2013-03-15 2023-08-29 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10120539A (en) * 1996-10-22 1998-05-12 Sunstar Inc Liquid composition for oral cavity
JPH10212220A (en) * 1997-01-30 1998-08-11 Lion Corp Oral composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10120539A (en) * 1996-10-22 1998-05-12 Sunstar Inc Liquid composition for oral cavity
JPH10212220A (en) * 1997-01-30 1998-08-11 Lion Corp Oral composition

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US10676501B2 (en) 2011-07-20 2020-06-09 Brigham Young University Hydrogel materials incorporating eluting ceragenin compound
US9546195B2 (en) 2011-07-20 2017-01-17 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9345655B2 (en) 2011-12-21 2016-05-24 Brigham Young University Oral care compositions
JP2015502978A (en) * 2011-12-21 2015-01-29 ブリガム ヤング ユニバーシティ Oral care composition
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
US10039285B2 (en) 2012-05-02 2018-08-07 Brigham Young University Ceragenin particulate materials and methods for making same
US9314472B2 (en) 2012-10-17 2016-04-19 Brigham Young University Treatment and prevention of mastitis
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US10195215B2 (en) 2013-01-07 2019-02-05 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11739116B2 (en) 2013-03-15 2023-08-29 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US11286276B2 (en) 2014-01-23 2022-03-29 Brigham Young University Cationic steroidal antimicrobials
US10626139B2 (en) 2014-02-27 2020-04-21 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US11253634B2 (en) 2016-03-11 2022-02-22 Brigham Young University Cationic steroidal antibiotic compositions for the treatment of dermal tissue
JP2017031201A (en) * 2016-09-30 2017-02-09 ブリガム ヤング ユニバーシティ Oral care composition
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Also Published As

Publication number Publication date
JP4674980B2 (en) 2011-04-20

Similar Documents

Publication Publication Date Title
JP4674980B2 (en) Alcohol-free liquid oral composition
JPH08505876A (en) Low alcohol mouthwash fungicide and germicidal formulation
RU2552936C2 (en) Oral care product and methods for use and production thereof
JPH0747531B2 (en) Oral composition
JPH0665034A (en) Detergent composition for oral cavity
JPH09286712A (en) Composition for oral cavity
JP5842565B2 (en) Mouthwash composition and method for inhibiting discoloration in mouthwash composition
JP3022039B2 (en) Oral composition for preventing tooth coloring
JPWO2003055459A1 (en) Oral composition
JP2000344641A (en) Composition for oral cavity
JP4044748B2 (en) Oral liquid composition
JP3783096B2 (en) Oral composition
JP2000178150A (en) Liquid composition for oral cavity
JPH05339135A (en) Composition for oral cavity
JPH1017444A (en) Amino acid-based surfactant-containing composition for oral cavity
JP2004161719A (en) Alcohol-free liquid composition for oral cavity application
JPH1112144A (en) Liquid oral composition
JPH10120539A (en) Liquid composition for oral cavity
JP2531132B2 (en) Mouthwash
JP2000053547A (en) Composition for oral cavity
JPH07267840A (en) Composition for oral cavity
JP2000053546A (en) Mouth rinsing agent
JP3838604B2 (en) Liquid oral composition
JP2019206486A (en) Composition for oral cavity
JP3417650B2 (en) Toothpaste composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080225

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100713

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100811

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101026

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101101

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110118

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110125

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140204

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4674980

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R255 Notification that request for automated payment was rejected

Free format text: JAPANESE INTERMEDIATE CODE: R2525

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term